Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Selective JAK inhibitors in development for rheumatoid arthritis
HTML
Details
Locations
Year:
2014
Type:
review
Source:
Expert Opinion on Investigational Drugs
DOI:
10.1517/13543784.2014.918604
Author:
Peter Norman
Language:
English
Topic:
Rheumatoid Arthritis Research and Therapies
Subfield:
Rheumatology
Field:
Medicine
Domain:
Health Sciences
Keywords:
JAK inhibitors,
rheumatoid arthritis,
baricitinib,
filgotinib,
tofacitinib,
peficitinib,
cytokine receptor signalling,
ACR20 response,
adverse effects
show all 9
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2096906176
FWCI:
2.637
Cites:
52
Cited by:
164
Related to:
10